Vij, R Martin, T Richter, J Cole, C Atanackovic, D Zonder, J Kaufman, J Mikhael, J Bensinger, W Dimopoulos, M others, Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 MAB) in relapsed/refractory multiple myeloma (RRMM), 82--83, 2016,